In addition to the upregulation of PD-1 on T-cells, its ligand PD-L1 is highly expressed on peritumoural stroma cells as well as cancer cells, promoting a PD-L1/PD-1 pathway-driven inhibition of anti-tumour T-cell responses [29,30,31]. Here, CD274 is linked to cancer.